Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai OPM Biosciences is a leading Chinese provider of integrated cell culture media products and end-to-end biologics CDMO services. It supports biopharmaceutical companies in antibody discovery, process development, pilot/clinical manufacturing of mAbs/recombinant proteins/vaccines/cell & gene therapies. The company operates globally with cGMP facilities in China and the US. Over 200 clinical therapeutics have been developed using its products or services; however, it does not develop proprietary drugs itself.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai OPM Biosciences.